107 related articles for article (PubMed ID: 88972)
21. Factor VIII alters tubular organization and functional properties of von Willebrand factor stored in Weibel-Palade bodies.
Bouwens EA; Mourik MJ; van den Biggelaar M; Eikenboom JC; Voorberg J; Valentijn KM; Mertens K
Blood; 2011 Nov; 118(22):5947-56. PubMed ID: 21940821
[TBL] [Abstract][Full Text] [Related]
22. Detection of factor VIII/coagulant antigen in human liver tissue.
Stel HV; van der Kwast TH; Veerman EC
Nature; 1983 Jun 9-15; 303(5917):530-2. PubMed ID: 6406906
[TBL] [Abstract][Full Text] [Related]
23. A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction.
Mazurier C; Dieval J; Jorieux S; Delobel J; Goudemand M
Blood; 1990 Jan; 75(1):20-6. PubMed ID: 2104761
[TBL] [Abstract][Full Text] [Related]
24. The association of factor VIII with von Willebrand factor.
Lollar P
Mayo Clin Proc; 1991 May; 66(5):524-34. PubMed ID: 1903173
[TBL] [Abstract][Full Text] [Related]
25. Direct radioimmune detection in human plasma of the association between factor VIII procoagulant protein and von Willebrand factor, and the interaction of von Willebrand factor-bound procoagulant VIII with platelets.
Moake JL; Weinstein MJ; Troll JH; Chute LE; Colannino NM
Blood; 1983 Jun; 61(6):1163-73. PubMed ID: 6404328
[TBL] [Abstract][Full Text] [Related]
26. Influence of von Willebrand factor on the reactivity of human factor VIII inhibitors with factor VIII.
Gensana M; Altisent C; Aznar JA; Casaña P; Hernández F; Jorquera JI; Magallón M; Massot M; Puig L
Haemophilia; 2001 Jul; 7(4):369-74. PubMed ID: 11442641
[TBL] [Abstract][Full Text] [Related]
27. Intracellular cotrafficking of factor VIII and von Willebrand factor type 2N variants to storage organelles.
van den Biggelaar M; Meijer AB; Voorberg J; Mertens K
Blood; 2009 Mar; 113(13):3102-9. PubMed ID: 19088379
[TBL] [Abstract][Full Text] [Related]
28. Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo.
Hamilton KK; Fretto LJ; Grierson DS; McKee PA
J Clin Invest; 1985 Jul; 76(1):261-70. PubMed ID: 3160727
[TBL] [Abstract][Full Text] [Related]
29. The mutation Arg (53)----Trp causes von Willebrand disease Normandy by abolishing binding to factor VIII. Studies with recombinant von Willebrand factor.
Jorieux S; Tuley EA; Gaucher C; Mazurier C; Sadler JE
Blood; 1992 Feb; 79(3):563-7. PubMed ID: 1732004
[TBL] [Abstract][Full Text] [Related]
30. The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factor.
Kroner PA; Foster PA; Fahs SA; Montgomery RR
Blood; 1996 Feb; 87(3):1013-21. PubMed ID: 8562925
[TBL] [Abstract][Full Text] [Related]
31. A new method measuring the interaction between von Willebrand factor and coagulation factor VIII.
Karlman M; Holmström M; Wiman B
Thromb Res; 2011 Jan; 127(1):47-50. PubMed ID: 21094987
[TBL] [Abstract][Full Text] [Related]
32. Physiological Roles of the von Willebrand Factor-Factor VIII Interaction.
Kiouptsi K; Reinhardt C
Subcell Biochem; 2020; 94():437-464. PubMed ID: 32189311
[TBL] [Abstract][Full Text] [Related]
33. A role for the C2 domain of factor VIII in binding to von Willebrand factor.
Saenko EL; Shima M; Rajalakshmi KJ; Scandella D
J Biol Chem; 1994 Apr; 269(15):11601-5. PubMed ID: 7512568
[TBL] [Abstract][Full Text] [Related]
34. VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors.
Dasgupta S; Repessé Y; Bayry J; Navarrete AM; Wootla B; Delignat S; Irinopoulou T; Kamaté C; Saint-Remy JM; Jacquemin M; Lenting PJ; Borel-Derlon A; Kaveri SV; Lacroix-Desmazes S
Blood; 2007 Jan; 109(2):610-2. PubMed ID: 16985172
[TBL] [Abstract][Full Text] [Related]
35. von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia.
Kalambokis GN; Oikonomou A; Christou L; Kolaitis NI; Tsianos EV; Christodoulou D; Baltayiannis G
J Hepatol; 2016 Nov; 65(5):921-928. PubMed ID: 27297911
[TBL] [Abstract][Full Text] [Related]
36. Adhesion of platelets to human artery subendothelium: effect of factor VIII-von Willebrand factor of various multimeric composition.
Sixma JJ; Sakariassen KS; Beeser-Visser NH; Ottenhof-Rovers M; Bolhuis PA
Blood; 1984 Jan; 63(1):128-39. PubMed ID: 6418228
[TBL] [Abstract][Full Text] [Related]
37. Some factor VIII (FVIII) inhibitors recognise a FVIII epitope(s) that is present only on FVIII-vWF complexes.
Gilles JG; Lavend'homme R; Peerlinck K; Jacquemin MG; Hoylaerts M; Jorieux S; Mazurier C; Vermylen J; Saint-Remy JM
Thromb Haemost; 1999 Jul; 82(1):40-5. PubMed ID: 10456452
[TBL] [Abstract][Full Text] [Related]
38. Thrombin-mediated release of factor VIII antigen from human umbilical vein endothelial cells in culture.
Levine JD; Harlan JM; Harker LA; Joseph ML; Counts RB
Blood; 1982 Aug; 60(2):531-4. PubMed ID: 6807373
[TBL] [Abstract][Full Text] [Related]
39. Estrogen stimulates von Willebrand factor production by cultured endothelial cells.
Harrison RL; McKee PA
Blood; 1984 Mar; 63(3):657-64. PubMed ID: 6607757
[TBL] [Abstract][Full Text] [Related]
40. Lectin activity of the coagulation factor VIII/von Willebrand complex.
Santizo F; Zenteno E; Pina-Canseco S; Hernandez-Cruz P; Cruz MM; Mayoral LP; Pérez-Campos E; Martínez-Cruz R
Tohoku J Exp Med; 2009 Mar; 217(3):209-15. PubMed ID: 19282656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
